Cigna Group $CI Shares Acquired by Ontario Teachers Pension Plan Board

Ontario Teachers Pension Plan Board increased its holdings in Cigna Group (NYSE:CIFree Report) by 16.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,010 shares of the health services provider’s stock after purchasing an additional 1,559 shares during the period. Ontario Teachers Pension Plan Board’s holdings in Cigna Group were worth $3,640,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Valeo Financial Advisors LLC grew its holdings in Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after buying an additional 3,471,249 shares during the period. Nuveen LLC acquired a new stake in shares of Cigna Group in the first quarter worth approximately $727,905,000. Price T Rowe Associates Inc. MD grew its holdings in Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares during the period. GQG Partners LLC grew its holdings in Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in Cigna Group by 38.3% during the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock worth $542,796,000 after purchasing an additional 457,052 shares during the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at $15,354,600. This represents a 9.49% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO David Cordani bought 4,134 shares of the stock in a transaction dated Monday, November 3rd. The shares were acquired at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CI shares. Guggenheim decreased their price target on shares of Cigna Group from $350.00 to $309.00 in a report on Friday, October 31st. Wolfe Research reduced their target price on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, October 15th. Robert W. Baird set a $372.00 price target on Cigna Group in a research report on Thursday, August 14th. Barclays cut their price objective on Cigna Group from $383.00 to $300.00 and set an “overweight” rating on the stock in a report on Friday, October 31st. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $334.05.

View Our Latest Stock Analysis on CI

Cigna Group Stock Performance

Shares of NYSE:CI opened at $269.52 on Friday. The business’s 50-day simple moving average is $289.75 and its 200 day simple moving average is $301.13. The company has a market cap of $72.00 billion, a P/E ratio of 14.71, a PEG ratio of 0.88 and a beta of 0.44. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. Cigna Group has a one year low of $239.51 and a one year high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.64 by $0.19. The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. Cigna Group’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the company earned $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, sell-side analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be paid a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is 26.64%.

Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.